CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

HDFC Pharma and Healthcare Fund-Reg(G)

very highequitypharma & health care
17.22 0.30(1.78%) NAV as on 08 Apr 2026
-1.77 % 1 M
13 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.09

As on 28 Feb, 2026
age-icon Age :

2 yrs 6 m

Since 04 10 ,2023
exit_load Exit Load :

1%

aum AUM :

2,030.81 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

7.95

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Nikhil Mathur

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2026
Others 1.76 %
Equity 98.24 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.81 %
Divi's Laboratories Ltd.8.38 %
Glenmark Pharmaceuticals Ltd.6.62 %
Lupin Ltd.6.44 %
Max Healthcare Institute Ltd.6.36 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs67.31
Hospital & Healthcare Services29.11
Miscellaneous1.22
Medical Equipment/Supplies/Accessories0.61
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-20252025-2026
NAV in Rs (as on 31-Mar-2026)12.2915.9216.98
Net Assets(Rs Crores) (as on 31-Mar-2026) 800.65 1634.08 2030.81
Scheme Returns(%)(Absolute)23.3028.358.48
B'mark Returns(%)(Absolute)NANANA
Category Rank66/901/1027/120

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

HDFC Pharma and Healthcare Fund-Reg(G)Very HighEquity17.220.30(1.78%)NAV As on 08 Apr, 202604-Oct-2023Inception Date2,030.81AUM In Cr.13.00%1YNA%3YNA%5Y24.33%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity275.053.87(1.43%)NAV As on 08 Apr, 202601-Aug-2005Inception Date1,055.53AUM In Cr.6.78%1Y23.55%3Y13.92%5Y17.37%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity37.740.33(0.89%)NAV As on 08 Apr, 202602-Jul-2018Inception Date2,843.74AUM In Cr.8.48%1Y22.60%3Y14.07%5Y18.64%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.